Skip to main content
Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · IEX Real-Time Price · USD
0.298
-0.021 (-6.58%)
At close: Jul 2, 2024, 3:59 PM
0.300
+0.002 (0.60%)
After-hours: Jul 2, 2024, 7:26 PM EDT

Psyence Biomedical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
 20222021
Selling, General & Admin
1.290.33
Operating Expenses
1.290.33
Operating Income
-1.29-0.33
Other Expense / Income
-9.31-8.56
Pretax Income
8.018.23
Net Income
8.018.23
Net Income Growth
-2.63%-
Shares Outstanding (Basic)
3313
Shares Outstanding (Diluted)
3313
Shares Change
156.47%-
EPS (Basic)
0.250.65
EPS (Diluted)
0.250.65
EPS Growth
-61.54%-
Free Cash Flow
-0.52-0.84
Free Cash Flow Per Share
-0.02-0.07
EBITDA
8.018.23
EBIT
8.018.23
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).